Krsnaa Diagnostics Limited · NSE:KRSNAA
Krsnaa Diagnostics — Q1 FY2026-27 Earnings Presentation
26 slides from Krsnaa Diagnostics's earnings presentation, Aug 14, 2026
Slide 1: Regulation 30 intimation cover letter
Date: August 14, 2026 Ref. No.: KDL/SE/029/2026-27 To, To, BSE Limited National Stock Exchange of India Limited Corporate Relationship Department Exchange Plaza, Plot No. C-1, Block G, 25th Floor, Phiroze Jeejeebhoy Towers Bandra Kurla Complex, Bandra (East) Dalal Street, Mumbai- 400001 Mumbai – 400
Slide 2: Q1 FY2026-27 Result Presentation
Q1 FY2026-27 Result Presentation One of INDIA’S LARGEST Integrated Diagnostic Service Provider
Slide 3: Disclaimer
Disclaimer This presentation contains statements that are “forward-looking statements”, including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements pertaining to Krsnaa Diagnostics’ future business developments and economic performance.
Slide 4: Krsnaa Diagnostics at a glance
191 221 Mn+ 76 CT/ MRI Centres 8,400+ Tests in Patient Touch Points in 5 Years Million+ 64% Patients Served YoY Retail Revenue In Last 5 Years Growth 333 212 19 Pathology Labs States/UT Districts 75% Presence Centers Cover Rural Presence in India PAN India Areas of India One of India’s largest NABH-
Slide 5: Q1 FY27 Financial Performance
Q1 FY27 Financial Performance Particulars Q1 FY27 Q1 FY26 Growth Particulars Q1 FY27 Q1 FY26 Growth Revenue 2,355 1,930 22% No. of Test Performed 16.1 15.8 2% (Mn) EBIDTA 588 524 12% No. of Patient Served 5.1 5.0 2% (Mn) EBIDTA Margin 25% 27% (221 bps) NABL Accreditation 54 54 - (Pathology lab) PAT
Slide 6: Retail Business Summary
Retail Business Summary Revenue Retail Revenue Retail Revenue Patient Count Test Volume (INR Mn) (Mn) (Mn) Per Patient Contribution to (INR) Group Revenue 193 0.21 0.47 950 931 0.32 Q1 FY26 Q1 FY27 118 0.12 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 Q1 FY26 Q1 FY27 1% 8% Up 64% YoY Up 75% YoY U
Slide 7: Q1 FY27 – Network Update
Q1 FY27 – Network Update THE SCALE-UP From a network of centres to a broader and scaled, diagnostic platform across Radiology and Pathology, built for sustained accessibility. RADIOLOGY PATHOLOGY Resilient scale. Larger ambition. Depth meets last-mile reach. The platform continues to expand despite
Slide 8: Driving Excellence Through Quality
Driving Excellence Through Quality India’s 1st ACR Accredited Company India’s 1st CAP Accredited Lab India’s 1st NABH Accredited at Government Facility Tele-Radiology Hub Service Excellence Pioneers of Indian Diagnostic Industry © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 7
Slide 9: Driving Excellence Through Quality
Driving Excellence Through Quality ACCREDITATION LEADER ACCREDITATION FOOTPRINT 120 Krsnaa leads the peer set by a wide margin Total NABL + NABH accreditation count Krsnaa 120 TOTAL ACCREDITATIONS Peer A 53 Peer B 44 2.3 × Next Peer Peer C 42 Peer D 31 66 54 Peer E 27 NABH NABL accredited centers ac
Slide 10: Presence - PAN India
Presence - PAN India Well Diversified Regional Revenue Mix 10% 39% Q1 FY27 40% 11% West South North East Krsnaa Presence India map for representation only, not to scale © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 9
Slide 11: Competitive Advantages
Competitive Advantages THE GROWTH STORY Reach → Capacity → Trust → Cash Conversion NEXT PHASE: CASH GROWTH 01 FOUNDATION 02 SCALE - THE ADVANTAGE 03 WAY FORWARD A scaled platform Building a larger and Turn network strength more sustainable cash already in place. into consumer growth. business. 2 Cr+
Slide 12: Growth Drivers
Growth Drivers POLICY TAILWINDS 3.3% → 5% Long Tenure Captive Consumer Cost Leadership Healthcare GDP (by 2030) Predictable & Long-term Government OPD & IPD patients Cost Optimisation: Business outlook: attributed to: • Radiology avg tenure term • District Hospitals • Volume-driven economies of $1,5
Slide 13: Our Pricing - "Everyone Can Afford"
Our Pricing - “Everyone Can Afford” % lower from Segment Test Competition 1 Competition 2 Competition 3 Krsnaa competitors Radiology CT Brain 4,500 4,500 3,500 880 (75)% Radiology MRI Brain 8,000 8,250 7,000 1,340 (81)% Pathology CBC 250 250 200 37 (82)% Pathology Blood Sugar 85 80 70 20 (71)% Patho
Slide 14: Retail Key Strength
Retail Key Strength Forward Growth Horizon: Scale | Awareness | Technology Pillar A: Scale & Modality Advantage Pillar B: Awareness Pillar C: AI-Enabled Diagnostics PPP-Based Ecosystem Aggregator & Platform Partnerships Technology as a Scale Multiplier PPP Infrastructure Leverage RPL on Health Platf
Slide 15: Retail-Forward Growth Journey
Retail-Forward Growth Journey Six engines powering a retail-led growth platform EXPAND • DEEPEN • PREVENT • PENETRATE • COLLECT • CONVERT EXPAND DEEPEN PREVENT 01 7–8 02 1,000+ 03 ~10–15% Strategic Expansion Network Depth Retail Preventive Wellness Retail States Centres Revenue New geographies Exist
Slide 16: Patient Experience at Its Best
Patient Experience at Its Best
Slide 17: Growth Engine- Enabling Reliable Diagnostics
Growth Engine- Enabling Reliable Diagnostics Amravati, Maharashtra Nanded, Maharashtra Actual centre images © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 16
Slide 18: Growth Engine- Rajasthan Pathology
Growth Engine- Rajasthan Pathology Kishanpole, Mother Lab Nagaur, Mother Lab Actual centre images © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 17
Slide 19: Activities in Retail Business: Doctor Engagement Activities
Activities in Retail Business Doctor Engagement Activities © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 18
Slide 20: Activities in Retail Business: Health Checkup Camp/Awareness Programs
Activities in Retail Business Health Checkup Camp/Awareness Programs © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 19
Slide 21: Activities in Retail Business: Medical Conferences
Activities in Retail Business Medical Conferences © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 20
Slide 22: Activities in Retail Business: Center Branding
Activities in Retail Business Center Branding © Krsnaa Diagnostics Ltd. All Rights Reserved. Copyright 2026 21
Slide 23: Financial Performance
DIAGNOSTICS Financial Performance
Slide 24: Consolidated Financial Performance
Consolidated Financial Performance In INR Mn Particulars Q1 FY 27 Q1 FY 26 Q4 FY 26 Amount % Amount % Amount % Revenue from operations 2,355 1,930 1,926 Expenses Cost of Material Consumed 502 21% 474 25% 444 23% Employee benefits expense 357 15% 350 18% 327 17% Fees to hospitals and others 406 17% 1
Slide 25: Contact Information
Contact Information This presentation contains statements that are “forward looking statements” including, but without limitation, statements relating to the implementation of strategic initiatives, and other statements relating to Krsnaa Diagnostics’ future business developments and economic perfor
Slide 26: Krsnaa Diagnostics
For further information please contact Krsnaa Diagnostics Sujoy Bose, Head- Secretarial, Legal and Compliance [email protected] Contact: +91 73910 40109 https://krsnaadiagnostics.com
Krsnaa Diagnostics — Q1 FY2026-27 Earnings Presentation on 6ix